Novartis Reveals Probe Of Plant Quality Issues
Novartis AG announced Wednesday that two of its units were under civil and criminal investigations by the U.S. Department of Justice over alleged vaccine-related quality issues at their production facilities, compounding...To view the full article, register now.
Already a subscriber? Click here to view full article